When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Pharmacology of antidepressants - Wikipedia

   en.wikipedia.org/wiki/Pharmacology_of...

   The pharmacology of antidepressants is not entirely clear.. The earliest and probably most widely accepted scientific theory of antidepressant action is the monoamine hypothesis (which can be traced back to the 1950s), which states that depression is due to an imbalance (most often a deficiency) of the monoamine neurotransmitters (namely serotonin, norepinephrine and dopamine). [1]

3. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

4. Your Guide to the 6 Most Common Types of Depression Medications

   www.aol.com/6-types-depression-medications...

   Duloxetine is one of the most commonly used prescription medications in the U.S. Patients with depression are usually prescribed 40 to 60 milligrams per day, with a potential increase of up to 120 ...

5. Serotonin–norepinephrine reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Serotonin–norepinephrine...

   The non-tricyclic SNRIs have several important differences that are based on pharmacokinetics, metabolism to active metabolites, inhibition of CYP isoforms, effect of drug-drug interactions, and the half-life of the nontricyclic SNRIs. [28] [35]

6. Dextromethorphan/bupropion - Wikipedia

   en.wikipedia.org/wiki/Dextromethorphan/bupropion

   The elimination half-lives of bupropion active metabolites are 35 hours for hydroxybupropion, 44 hours for erythrohydrobupropion, and 33 hours for threohydrobupropion. [1] Bupropion inhibits the metabolism of dextromethorphan by inhibiting the enzyme CYP2D6, the major enzyme responsible for the metabolism of dextromethorphan. [1]

7. Breakthrough antidepressants with fewer side effects could ...

   www.aol.com/finance/breakthrough-antidepressants...

   The FDA approved Johnson & Johnson’s drug for treatment-resistant depression in 2019. Esketamine is derived from a pediatric anesthetic called ketamine. Through research pioneered at Yale ...